Historically, ACS headquarters costs averaged approximately €60 million annually between 2012 and 2023, representing about 3% of the company’s EBITDA. Meanwhile, its subsidiary Hochtief saw ...

PARIS (Reuters) -French actress Charlotte Arnould wrote on social media on Tuesday that film star Gerard Depardieu had been ordered to face trial for allegedly raping her. The Paris prosecutor’s ...

Constantly rebalancing risks and updating its list of picks every month is the key secret that has led our AI models to notch a jaw-dropping 130.74% return since launch in November 2023, more than 91% ...

Due to the size of the dividend representing more than 20% of the company’s stock price, NYSE American has advised that UUU shares will trade with "due bills" from September 18 through September 25, ...

Flutter Entertainment ’s London-listed stock is only marginally lower, though its U.S.-listed shares are down 2.9% in premarket trading. DraftKings, in which Flutter holds a stake, is 1.2% lower ahead ...

Piper Sandler revised its earnings per share estimates for Columbia Banking to $2.54 for 2025 and $3.16 for 2026, compared to previous estimates of $2.64 and $2.95, respectively. The firm also ...

Gemini Space Station Inc., a cryptocurrency platform, filed a registration statement with the Securities and Exchange Commission for an initial public offering of 16,666,667 shares of Class A common ...

Zscaler was also upgraded, with Morgan Stanley pointing to its strong positioning in the $34 billion SASE market, expected to grow at a 24% CAGR. The bank said Zscaler “could cement itself as the next ...

Looking ahead, Raymond James pointed out that earnings growth across midcap and small-cap indexes is expected to accelerate in late 2025 and into 2026. Still, it cautioned: “The earnings expectations ...

Klarna (KLAR) has filed for a 34,311,274 share NYSE IPO at $35-$37 per share. The company is offering 5,555,556 ordinary shares, and the selling shareholders are offering an additional 28,755,718 ...

RBC’s scenario analysis places Eni’s downside case at €10, representing a 28% fall from current levels, and an upside case at €22, a 50% gain.

Investing.com -- Cytokinetics (NASDAQ:CYTK) stock surged 31% after the company reported impressive data from its MAPLE-HCM trial comparing its experimental heart drug aficamten to the standard-of-care ...